Scabronine G Methyl Ester Improves Memory-Related Behavior and Enhances Hippocampal Cell Proliferation and Long-Term Potentiation via the BDNF-CREB Pathway in Olfactory Bulbectomized Mice

被引:16
|
作者
Nakagawasai, Osamu [1 ]
Lin, Jia-Rong [1 ]
Odaira, Takayo [1 ]
Takahashi, Kohei [1 ,2 ]
Nemoto, Wataru [1 ]
Moriguchi, Shigeki [3 ,4 ]
Yabuki, Yasushi [4 ,5 ]
Kobayakawa, Yu [6 ]
Fukunaga, Kohji [4 ]
Nakada, Masahisa [6 ]
Tan-No, Koichi [1 ]
机构
[1] Tohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi, Japan
[2] Int Univ Hlth & Welf, Sch Pharm, Dept Pharmacol, Ohtawara, Japan
[3] Tohoku Univ, Grad Sch Pharmaceut Sci, Res Ctr Pharmaceut Dev, Sendai, Miyagi, Japan
[4] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi, Japan
[5] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Genom Neurol, Kumamoto, Japan
[6] Waseda Univ, Dept Chem & Biochem, Fac Sci & Engn, Tokyo, Japan
来源
FRONTIERS IN PHARMACOLOGY | 2020年 / 11卷
关键词
long-term potentiation; memory; olfactory bulbectomy; scabronine G methyl ester; cell proliferation; CAM KINASE-II; NEUROTROPHIC FACTOR; DENTATE GYRUS; COGNITIVE IMPAIRMENT; ANTIDEPRESSANT DRUGS; NEUROGENESIS; RAT; ACTIVATION; RECEPTOR; MODEL;
D O I
10.3389/fphar.2020.583291
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A previous study reported that scabronine G methyl ester (SG-ME) potentially enhances the in vitro secretion of neurotrophic factors such as nerve growth factor via the protein kinase C (PKC)-zeta pathway. However, it remains unknown whether SG-ME can improve cognitive dysfunctions in olfactory bulbectomized (OBX) mice. To address this question, we evaluated SG-ME-treated and untreated OBX mice in a passive avoidance test. We also investigated potential effects of SG-ME on several parameters: cell proliferation and cAMP response element-binding protein (CREB) phosphorylation in the hippocampal dentate gyrus by immunohistochemistry, brain-derived neurotrophic factor (BDNF) levels in the hippocampus by Western blotting, p-CREB levels in the hippocampus by MapAnalyzer, and long-term potentiation (LTP) by electrophysiology. On the 14th day after surgery OBX mice showed altered passive avoidance and decreases in both cell proliferation and long-term potentiation in the hippocampus, while these changes were reversed by SG-ME (20 mu g/mouse) 24 h after the treatment. The improvement in memory deficits was prevented when SG-ME was co-administeredwith either zeta inhibitory peptide (PKC-zeta inhibitor), anti-BDNF antibody, ANA-12 (TrkB antagonist), U0126 (MEK inhibitor), H-89 (PKA inhibitor), LY294002 (PI3K inhibitor) or KN-93 (CaMKII inhibitor). We found that SG-ME enhanced brain-derived neurotrophic factor and p-CREB levels in the hippocampus while p-CREB was localized in neurons, but not in astrocytes nor microglial cells. These findings revealed the potential of SG-ME in improving memory impairments by enhancing cell proliferation and LTP via activation of the BDNF/CREB signaling pathway in neurons.
引用
收藏
页数:13
相关论文
empty
未找到相关数据